Hipo.K
HIPO.K operates as a multiline insurance and broker within the Financials sector, generating revenue through insurance premiums and brokerage activities.
Business. HIPO.K operates as a multiline insurance and broker within the Financials sector, generating revenue through insurance premiums and brokerage activities.
Analyst recommendations
6 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
- Congressional trades
- CongressMarie Newman — Hippo Holdings Inc.2021-11-19 · IL · Purchase · $1,001 - $15,000
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
HIPO.K operates as a multiline insurance and broker within the Financials sector, generating revenue through insurance premiums and brokerage activities.
HIPO.K maintains a conservative capital structure with a debt-to-equity ratio of 0.0, indicating no interest-bearing debt on the balance sheet. The company holds $218.3 million in cash and equivalents against total liabilities of $1,469.4 million, resulting in a low liquidity risk assessment. With a market capitalization of $778.4 million and a price-to-book ratio of 1.79, the equity is valued at a premium to its book value of $436.1 million. The current ratio is not explicitly provided, but the absence of debt and significant cash holdings suggest adequate short-term solvency.
Profitability metrics show a return on equity (ROE) of 13.23% and a return on assets (ROA) of 3.03% for the latest period. The company generated $57.7 million in net income on $468.6 million in revenue, implying a net margin of approximately 12.3%. The price-to-earnings ratio stands at 13.49, suggesting the market prices the earnings at a moderate multiple. Without cohort median data provided in the input, direct comparative analysis against industry peers is omitted, but the positive ROE and ROA indicate efficient use of capital.
Revenue concentration by segment or geography is not detailed in the available data. The company is classified as a multiline insurer and broker, implying a diversified product mix, but specific revenue breakdowns are absent. Consequently, concentration risk cannot be quantified from the provided segments or geography sections.
Growth trajectory analysis is limited by the absence of historical period data in the input. The latest normalized period shows revenue of $468.6 million and net income of $57.7 million. Without prior year or quarterly trend data, year-over-year growth rates cannot be calculated. The operating cash flow of $9.2 million is significantly lower than net income, suggesting potential working capital adjustments or non-cash income items, while capital expenditure is negligible at $0.1 million.
Risk assessment indicates low liquidity risk and low dilution risk. The key flags section reports no immediate filing-based liquidity or dilution concerns. The shares outstanding are identical for basic and diluted counts (25,699,704), confirming no current dilutive securities such as options or warrants are impacting the share count. The primary risk appears to be operational or market-related rather than structural financial distress.
Recent observations include analyst estimates with a mean price target of $41.20 and a median of $43.00, representing a potential upside from the current market price of $30.29. The mean recommendation is 2.17, leaning towards a buy rating with 1 strong buy and 3 buy ratings versus 2 holds. News events indicate system reconciler activities for coverage closure, but no specific corporate actions or material news events are disclosed in the observations.
- Debt-free balance sheet with $218.3 million in cash provides strong financial flexibility.
- ROE of 13.23% and P/E of 13.49 suggest reasonable profitability relative to valuation.
- Analyst consensus indicates upside potential with a mean target of $41.20 vs current $30.29.
- No dilution risk identified as basic and diluted shares are identical.
- Operating cash flow ($9.2M) is low relative to net income ($57.7M), warranting monitoring of cash conversion.
Bull / Bear case
analysis pipelineIn focus — financials by report
Operating income +115,7% YoY; Net income +114,9% YoY.
- ▍Operating income +115,7% YoY
- ▍Net income +114,9% YoY
- ▍Free cash flow +120,4% YoY
Operating income −84,9% YoY; Net income −86,4% YoY.
- ▍Operating income −84,9% YoY
- ▍Net income −86,4% YoY
- ▍Free cash flow −85,8% YoY
Operating income +1 966,0% YoY; Net income +1 254,1% YoY.
- ▍Operating income +1 966,0% YoY
- ▍Net income +1 254,1% YoY
- ▍Free cash flow +3 777,8% YoY
Operating income +111,3% YoY; Net income +103,2% YoY.
- ▍Operating income +111,3% YoY
- ▍Net income +103,2% YoY
- ▍Free cash flow +116,5% YoY
Operating income -$45.8M.
- ▍Operating income -$45.8M
Operating income $47.1M.
- ▍Operating income $47.1M
Operating income -$5.3M.
- ▍Operating income -$5.3M
Operating income -$36.4M.
- ▍Operating income -$36.4M
Operating income +333,8% YoY; Net income +242,5% YoY.
- ▍Operating income +333,8% YoY
- ▍Net income +242,5% YoY
- ▍Free cash flow +500,6% YoY
Operating income +89,6% YoY; Net income +85,2% YoY.
- ▍Operating income +89,6% YoY
- ▍Net income +85,2% YoY
- ▍Free cash flow +94,0% YoY
Operating income +19,6% YoY; Net income +18,1% YoY.
- ▍Operating income +19,6% YoY
- ▍Net income +18,1% YoY
- ▍Free cash flow +12,7% YoY
Operating income −94,7% YoY; Net income +10,2% YoY.
- ▍Operating income −94,7% YoY
- ▍Net income +10,2% YoY
- ▍Free cash flow +11,3% YoY
Valuation TTM
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 0,33 |
| Revenue | —no estimate | —no estimate | 569,5M USD |
| Operating income | —no estimate | —no estimate | 11,5M USD |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Reference data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Cash Conversion Ratiooperating_cash_flow / net_income
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Ev To Revenueenterprise_value / revenue
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Return On Equitynet_income / total_equity
- Market Capmarket_price * shares_outstanding_diluted
- HIPPO HOLDINGS INC. Market data — financials · 2026-07-29
- reconciler_enqueue (reconciler) on HIPO.K · 2026-07-29
- Hippo Holdings Inc Market data — analyst estimates · 2026-07-29
- Hippo Holdings Inc Market data — ESG · 2026-07-29
- HIPO.K HA canonical relationships · 2026-07-29
Ownership & reference
Top holders
- Investment Managers · as of 2026-03-310,00 %$10M
- Investment Managers · as of 2026-03-310,00 %$15M
- Investment Managers · as of 2026-03-310,00 %$4M
- Investment Managers · as of 2026-03-310,00 %$5M
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2025-12-310,00 %$37M
- Investment Managers · as of 2024-06-300,00 %$22M
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$3M
- Investment Managers · as of 2024-12-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$11M
- Investment Managers · as of 2026-03-310,00 %$6M
- Institutional Investor · as of 2026-03-310,00 %$2M
- Institutional Investor · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$0M
- Institutional Investor · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$0M
- Funds · as of 2026-03-310,00 %$0M
- Brokerage Firms · as of 2026-03-310,00 %$0M
- Institutional Investor · as of 2026-03-310,00 %$0M
- Institutional Investor · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
Leadership
- Assaf WandExecutive Chairman of the Board
Insider activity
- Chief Financial Officer · Common StockSold 1 669 @ $30,98$52K · 2026-07-28
- Director, Chief Executive Officer · Common StockSold 5 000 @ $28,53$143K · 2026-07-09
- Chief Operating Officer · Common StockOther 11 674 · 2026-06-10
- Director, Chief Executive Officer · Common StockSold 5 000 @ $25,00$125K · 2026-06-09
- Director · Common StockOther 4 820 · 2026-06-03
- Director · Common StockOther 4 738 @ $25,40$120K · 2026-06-02
- Director · Common StockOther 4 808 · 2026-06-02
- Director · Common StockOther 4 738 @ $25,40$120K · 2026-06-02
- Director · Common StockOther 4 808 · 2026-06-02
- Director · Common StockOther 2 502 @ $25,40$64K · 2026-06-02
- Director · Common StockOther 4 808 · 2026-06-02
- Director · Common StockOther 2 502 @ $25,40$64K · 2026-06-02
- Director · Common StockOther 4 808 · 2026-06-02
- Director · Common StockOther 4 738 @ $25,40$120K · 2026-06-02
- Director · Common StockOther 4 808 · 2026-06-02
- Director · Common StockOther 4 738 @ $25,40$120K · 2026-06-02
- Director · Common StockOther 4 738 @ $25,40$120K · 2026-06-02
- Director · Common StockOther 4 808 · 2026-06-02
- Director · Common StockOther 4 738 @ $25,40$120K · 2026-06-02
- Director · Common StockOther 4 808 · 2026-06-02
- Director · Common StockOther 4 808 · 2026-06-02
- Director · Common StockOther 4 738 @ $25,40$120K · 2026-06-02
- CEO Spinnaker · Common StockOther 1 340 @ $26,41$35K · 2026-05-15
- GM & Chief Insurance, HHIP · Common StockOther 1 259 @ $26,41$33K · 2026-05-15
- CEO Spinnaker · Common StockSold 3 667 @ $26,10$96K · 2026-05-15
Short positioning
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): -80.6%Derived (calculated)
- Capex (YoY) (2025-12-31 vs 2024-12-31): -66.7%Derived (calculated)
- Debt-to-equity (FY 2025-12-31): 3.37xDerived (calculated)
- Return on assets (FY 2025-12-31): 3.3%Derived (calculated)
- Net margin (FY 2025-12-31): 13.4%Derived (calculated)
- Return on equity (FY 2025-12-31): 14.4%Derived (calculated)
- Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): 10.5%Derived (calculated)
- Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 24.7%Derived (calculated)
- EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): 239.0%Derived (calculated)
- Net income (YoY) (2025-12-31 vs 2024-12-31): 318.9%Derived (calculated)
- Total assets (YoY) (2025-12-31 vs 2024-12-31): 23.5%Derived (calculated)
- Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): 20.4%Derived (calculated)
- Revenue (YoY) (2025-12-31 vs 2024-12-31): 25.9%Derived (calculated)
- EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): 235.4%Derived (calculated)
- Total liabilities (annual): USD 1.47BSEC XBRL filing
- Cash & equivalents (annual): USD 218.3MSEC XBRL filing
- Pre-tax income (annual): USD 63.3MSEC XBRL filing
- EPS (basic) (annual): USD-PER-SHARES 2SEC XBRL filing
- EPS (diluted) (annual): USD-PER-SHARES 2SEC XBRL filing
- Capex (annual): USD 100KSEC XBRL filing
- Shareholders' equity (annual): USD 436.1MSEC XBRL filing
- Revenue (annual): USD 468.6MSEC XBRL filing
- Net income (annual): USD 62.6MSEC XBRL filing
- Operating cash flow (annual): USD 9.2MSEC XBRL filing